One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy

Journal of the Formosan Medical Association

Volumn 97, Issue 4, 1998, Pages 266-270

  Sheu, Bor Shyang ^a,b   Wu, Jiung Juo ^a   Yang, Hsiao Bai ^a   Huang, Ay Huey ^a   Lin, Xi Zhang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Clarithromycin; Helicobacter pylori; Metronidazole; Proton pump inhibitor

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROSCOPY; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; PEPTIC ULCER; STOMACH BIOPSY; TAIWAN; TREATMENT FAILURE; VERTIGO; VOMITING;

ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PEPTIC ULCER; PROTON PUMPS; TREATMENT FAILURE;

EID: 0031945930     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Labenz J, Gyenes E, Ruhl GH, et al: Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993;34:1167-70.
2. Labenz J, Gyenes E, Ruhl GH, et al: Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993,88:491-5.
3. Rokkas T, Mavrogeorgis A, Liatsos C, et al: Optimal dose of omeprazole in combination with amoxicillin in eradicating H. pylori and preventing relapses in duode-nal ulcer patients. Hepatogastroenterology 1995;42: 842-6.
4. Jaup BH. Norrby A: Low dose, short-term triple therapy for cure of Helicobacter pylori infection and peptic ulcers. Am J Gastroenterol 1995;90:943-5.
5. Yousfi MM, El-Zimaity HM, Al-Assi MT, et al: Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:209-12.
6. Andrew H: Medical treatment of peptic ulcer disease-practical guidelines. JAAM 1996;8:622-9.
7. van der Hulst RWM, Keller JJ, Rauws FAJ, et al: Treatment of Helicobacter pylori infection: a review of world literature. Helicobacter 1996;1.6-19.
8. Lind T, Veldhuyzen van Zanten V, Unge P, et al. Eradication of Helicobacter pylon using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study. Helicobacter 1996;1:138-44.
9. Lin PZ, Yang JC, Yang CK, et al: Evolution of resistance rate of H pylon to metronidazole - 3 years' follow-up. Gastroenterol J Taiwan 1997;14:88.
10. Yang JC, Chen WH, Yang CK, et al: Evolution of resistance rate of H. pylori to clarithromycin - 3 years' followup. Gastroenterol J Taiwan 1997;14:88.
11. Morshkowitz M, Konikoff FM, Peled Y, et al: High Helicobacter pylori numbers are associated with low eradication rate after triple therapv. Gut 1995;36: 845-7.
12. Sheu BS, Yang SB, Su IJ, et al: Bacterial density of Helicobacter pylori predicts the success of triple therapv in bleeding duodenal ulcer. Gastrointest Endosc 1996; 43:683-8.
13. van der Hulst RW, Weel JF, van der Ende A, et al: Therapeutic options after failed Helicobacter pylori eradication therapy. Am J Gastroenterol 1996;91:2333-7.
14. Marshall BJ, Warren JR, Francis GJ, et al: Rapid urease test in the management of Campylobacter pyloritis-associated gastritis. Am J Gastroenterol 1987;82:200-10.
15. Genta RM, Rohason GO, Graham DY: Simultaneous visualization of Heluobacter pylori and gastric morphology: a new stain. Hum Pathol 1994;25:221-6.
16. Hachem CY, Clarridge JE, Reddy R, et al. Antimicrobial susceptibility testing of Helicobacter pylon. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diag Microbiol Inject Dis 1996;24:37-41.
17. Vakil N, McSorley DJ, Hahn B, et al: Clarithromycin-resistant H. pylori in United States [Abstract]. Gastroenterology 1997;112:A318.
18. Perschy TB, McSorley DJ, Sorrells SC, et al: Ranitidine bismuth citrate in combination with clarithromycin is effective against H. pyloristrains with susceptible or intermediate clarithromycin sensitivity [Abstract]. Gastroenterology 1997;112 A257.
19. Hirschl AM, Rotter ML: Amoxicillin for the treatment of Helicobacter pylon infection. J Gastroenterol 1996;31 (suppl 9):44-7.
20. Unge P, Berstad A: Pooled analysis of anti-Helicobacter pylori treatment regimens. Scand J Gastroenterol 1996;31 (suppl 220):27-40.
21. Axon AT, Moayyedi P: Eradication of Helicobacter pylori: omeprazole in combination with antibiotics. Scand J Gastroenterol 1996;31 (suppl 215):82-9.
22. Yang HB, Sheu BS, Su IJ, et al: Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci 1997;42: 1835-40.
23. Moayyedi P, Langworthy H, Shanahan K, et al: Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. Helicobacter 1996;1:71-4.
24. Buckley MJM, Deltenre M: Therapy of Helicobacter pylori infection. Curr Opin Gastroenterol 1997;13:56-62.
25. Lerang F, Mourn B, Haug JB, et al: Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997;28:248-53.